People

Olivier Meyer is a pharmaceutical scientist and biotechnology entrepreneur with lipid-nanovector and drug-delivery experience. GlioCure announced him as Vice-President Corporate Development in May2021 alongside its nanovector business expansion. His reported career included UCSF postdoctoral research, Transgene, AstraZeneca, Bioxalis Medica, Bioxel Pharma and founding Carlina Technologies. The role is historically sourced, not an assertion of current2026 tenure.